Numerical simulations of in vitro nanoparticle toxicity - the case of poly(amido amine) dendrimers

Toxicology in Vitro

Volumn 28, Issue 8, 2014, Pages 1449-1460

  Maher, Marcus A ^a   Naha, Pratap C ^a,b   Mukherjee, Sourav Prasanna ^b,c   Byrne, Hugh J ^a  

^a DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HEALTH CANADA   (Canada)

Author keywords

Cytotoxicity; Nanotoxicology; Numerical simulation; Polyamidoamine dendrimer; Quantitative structure activity relationships; Reactive oxygen species

Indexed keywords

EID: 84908674020     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2014.07.014     Document Type: Article

References (63)

1. Ankley G.T., Bennett R.S., Erickson R.J., Hoff D.J., Hornung M.W., Johnson R.D., Mount D.R., Nichols J.W., Russom C.L., Schmieder P.K., Serrrano J.A., Tietge J.E., Villeneuve D.L. Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ. Toxicol. Chem. 2010, 29:730-741.
2. Atkinson K.A. An Introduction to Numerical Analysis 1989, John Wiley & Sons, New York, ISBN 978-0-471-50023-0. second ed.
3. Balasundaram G., Sato M., Webster T.J. Using hydroxyapatite nanoparticles and decreased crystallinity to promote osteoblast adhesion similar to functionalizing with RGD. Biomaterials 2006, 27:2798-2805.
4. Bennett E.R., Clausen J., Linkov E., Linkov I. Predicting physical properties of emerging compounds with limited physical and chemical data: QSAR model uncertainty and applicability to military munitions. Chemosphere 2009, 77:1412-1418.
5. Bharali D.J., Khalil M., Gurbuz M., Simone T.M., Mousa S.A. Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers. Int. J. Nanomed. 2009, 4:1-7.
6. Black J.W., Leff P. Operational models of pharmacological agonism. Proc. R. Soc. B: Biol. Sci. 1983, 220:141-162.
7. Clark K.A., White R.H., Silbergeld E.K. Predictive models for nanotoxicology: current challenges and future opportunities. Regul. Toxicol. Pharm. 2011, 59:361-512.
8. Crooks R.M., Lemon B.I., Yeung L.K., Zhao M. Dendrimers III: design, dimension, function: dendrimer-encapsulated metals and semiconductors: synthesis, characterisation and applications. Topics Curr. Chem. 2001, 212:81-135.
9. De Jong W.H., Borm P.J.A. Drug delivery and nanoparticles: applications and hazards. Int. J. Nanomed. 2008, 3:133-149.
10. Dell'Orco D., Lundqvist M., Cedervall T., Linse S. Delivery success rate of engineered nanoparticles in the presence of the protein corona: a systems-level screening. Nanomed. Nanotechnol. Biol. Med. 2012, 8:1271-1281.
11. Deneke S.M., Fanburg B.L. Regulation of cellular glutathione. Am. J. Physiol. 1989, 257:L163-L173.
12. Einstein A. Strahlungs-emission und-absorption nach der Quantentheorie. Verhandlungen der Deutschen Physikalischen Gesellschaft 1916, 18:318-323.
13. European Union, 2010. Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes.
14. Guillot-Nieckowski M., Eisler S., Diederich F. Dendritic vectors for gene transfection. New J. Chem. 2000, 31:1111-1127.
15. Hans M.L., Lowman A.M. Biodegradable nanoparticles for drug delivery and targeting. Curr. Opin. Solid State Mater. 2002, 6:319-327.
16. Hong S., Bielinska A.U., Mecke A., Keszler B., Beals J.L., Shi X., Balogh L., Orr B.G., Baker J.R., Banasza kHoll M.M. Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport. Bioconjugate Chem. 2004, 15:774-782.
17. Issels R.D., Nagele A., Eckert K.-G., Wilmanns W. Promotion of cystine uptake and its utilization for glutathione biosynthesis induced by cysteamine and N-acetylcysteine. Biochem. Pharmacol. 1985, 37:1029-1033.
18. Jain K.K. Applications of nanobiotechnology in clinical diagnostics. Clin. Chem. 2007, 53:2002-2009.
19. Jain K., Kesharwani P., Gupta U., Jain N.K. Dendrimer toxicity: let's meet the challenge. Int. J. Pharm. 2010, 394:122-142.
20. Jeng H.A., Swanson J. Toxicity of metal oxide nanoparticles in mammalian cells. J. Environ. Sci. Health A 2006, 41:2699-2711.
21. Kennedy, I.M., Wilson, D., Barakat, A.I., 2009. Uptake and Inflammatory Effects of Nanoparticles in a Human Vascular Endothelial Cell Line. HEI Research Report 136, Health Effects Institute, Boston, MA.
22. Kitchens K.M., Foraker A.B., Kolhatkar R.B., Swaan P.W., Ghandehari H. Endocytosis and interaction of poly (Amidoamine) dendrimers with Caco-2 cells. Pharmaceut. Res. 2007, 24:2138-2145.
23. Koo O.M., Rubinstein I., Onyuksel H. Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomed. Nanotechnol. Biol. Med. 2005, 1:193-212.
24. Kukowska-Latallo J.F., Bielinska A.U., Johnson J., Spindler R., Tomalia D.A., Baker J.R. Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proc. Natl. Acad. Sci. USA 1996, 93:4897-4902.
25. Lee J.H., Cha K.E., Kim M.S., Hong H.W., Chung D.J., Ryu G., Myung H. Nanosized polyamidoamine (PAMAM) dendrimer-induced apoptosis mediated by mitochondrial dysfunction. Toxicol. Lett. 2009, 190:202-207.
26. Medina C., Santos-Martinez M.J., Radomski A., Corrigan O.I., Radomski M.W. Nanoparticles: pharmacological and toxicological significance. Brit. J. Pharmacol. 2007, 150:552-558.
27. Meng T., Xia T., George S., Nel A.E. A predictive toxicological paradigm for the safety assessment of nanomaterials. ACS Nano 2009, 3:1620-1627.
28. Miyazaki M., Nakade S., Iwanaga K., Morimoto K., Kakemi M. Estimation of bioavailability of salmon calcitonin from the hypocalcemic effect in rats (I): pharmacokinetic-pharmacodynamic modeling based on the endogenous Ca regulatory system. Drug Metabol. Pharmacokin. 2003, 18:350-357.
29. Mukherjee S.P., Byrne H.J. Polyamidoamine dendrimer nanoparticle cytotoxicity oxidative stress, caspase activation and inflammatory response: experimental observation and numerical simulation. Nanomed. Nanotechnol. Biol. Med. 2013, 9:202-211.
30. Mukherjee S.P., Davoren M., Byrne H.J. In vitro mammalian cytotoxicological study of PAMAM dendrimers - towards quantitative structure activity relationships. Toxicol. In Vitro 2010, 24:169-177.
31. Mukherjee S.P., Lyng F.M., Garcia A., Davoren M., Byrne H.J. Mechanistic studies of in vitro cytotoxicity of poly(amidoamine) dendrimers in mammalian cells. Toxicol. Appl. Pharm. 2010, 248:259-268.
32. Naha P.C., Byrne H.J. Generation of intracellular reactive oxygen species and genotoxicity effect to exposure of nanosized polyamidoamine (PAMAM) dendrimers in PLHC-1 cells in vitro. Aquat. Toxicol. 2013, 132-133:61-72.
33. Naha P.C., Davoren M., Casey A., Byrne H.J. An ecotoxicological study of poly(amidoamine) dendrimers-toward quantitative structure activity relationships. Environ. Sci. Technol. 2009, 43:6864-6869.
34. Naha P.C., Davoren M., Lyng F.M., Byrne H.J. Reactive oxygen species (ROS) induced cytokine production and cytotoxicity of PAMAM dendrimers in J774A.1 cells. Toxicol. Appl. Pharm. 2010, 246:91-99.
35. Nair H.B., Sung B., Yadav V.R., Kannappan R., Chaturvedi M.M., Aggarwal B.B. Delivery of anti-inflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer. Biochem. Pharmacol. 2010, 80(2010):1833-1843.
36. Nakagawa Y., Akao Y., Morikawa H., Hirata I., Katsu K., Naoe T., Ohishi N., Yagi K. Arsenic trioxide-induced apoptosis through oxidative stress in cells of colon cancer cell lines. Life Sci. 2002, 70:2253-2269.
37. Nel A., Xia T., Mädler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311:622-627.
38. Nishimura I., Huang Y., Butz F., Ogawa T., Lin A., Wang C.J. Discrete deposition of hydroxyapatite nanoparticles on a titanium implant with predisposing substrate microtopography accelerated osseointegration. Nanotechnology 2007, 18:1-9.
39. Nociari M.M., Shalev A., Benias P., Russo C. A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity. J. Immunol. Meth. 1998, 213:157-167.
40. Organisation for Economic Co-Operation and Development (OECD), 2007. Guidance Document on the Validation of (Quantitative) Structure Activity Relationships [(Q)SAR] Models, OECD, ENV/JM/MONO(2007) 2.
41. Organisation for Economic Co-Operation and Development (OECD), 2013. Guidance Document On Developing and Assessing Adverse Outcome Pathways, OECD, ENV/JM/MONO(2013) 6.
42. Oomen A., Bos P., Fernandes T., Hund-Rinke K., Boraschi D., Byrne H.J., Aschberger K., Gottardo S., von der Kammer F., Kühnel D., Hristozov D., Marcomini A., Migliore L., Scott-Fordsmand J., Wick P., Landsiedel R. Concern-driven integrated toxicity testing strategies for nanomaterials - Report of the NanoSafety Cluster Working Group 10. Nanotoxicology 2014, 8:334-348.
43. Project on Emerging Nanotechnologies (PEN), 2013. < http://www.nanotechproject.org/>.
44. Puzyn T., Leszczynska D., Leszczynski J. Toward the development of "Nano-QSARs": advances and challenges. Small 2009, 22:2494-2509.
45. Repetto G., del Peso A., Zurita J.L. Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat. Protocols 2008, 3:1125-1131.
46. Rothen-Rutishauser B., Mühlfeld C., Blank F., Musso C., Gehr P. Translocation of particles and inflammatory responses after exposure to fine particles and nanoparticles in an epithelial airway model. Part Fibre Toxicol. 2007, 4. http://dx.doi.org/10.1186/1743-8977-4-9.
47. Russell W.M.S., Burch R.L. The Principles of Humane Experimental Technique 1959, Methuen, London.
48. Ryan S.M., Frías J.M., Wang X., Sayers C.T., Haddleton D.M., Brayden D.J. PK/PD modelling of comb-shaped PEGylated salmon calcitonin conjugates of differing molecular weights. J. Control. Release 2011, 149:126-132.
49. Salvati A., Aberg C., dos Santos T., Varela J., Pinto P., Lynch I., Dawson K.A. Experimental and theoretical comparison of intracellular import of polymeric nanoparticles and small molecules: toward models of uptake kinetics. Nanomed. Nanotechnol. Biol. Med. 2011, 7:818-826.
50. Schins R.P., McAlinden A., MacNee W., Jimenez L.A., Ross J.A., Guy K., Faux S.P., Donaldson K. Persistent depletion of I kappa B alpha and interleukin-8 expression in human pulmonary epithelial cells exposed to quartz particles. Toxicol. Appl. Pharm. 2000, 167:107-117.
51. Shen L., Sevanian A. OxLDL induces macrophage γ-GCS-HS protein expression: a role for oxLDL-associated lipid hydroperoxide in GSH synthesis. J. Lipid Res. 2001, 42:813-823.
52. Shvedova A.A., Castranova V., Kisin E.R., Schwegler-Berry D., Murray A.R., Gandelsman V.Z., Maynard A., Baron P. Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells. J. Toxicol. Environ. Health A 2003, 66:1909-1926.
53. Snow E.T., Sykora P., Durham T.R., Klein C.B. Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk?. Toxicol. Appl. Pharm. 2005, 207:S557-S564.
54. Tomalia D.A., Fréchet J.M.J. Discovery of dendrimers and dendritic polymers: a brief historical perspective. J. Polym. Sci. Pol. Chem. 2002, 40:2719-2728.
55. Tsan M.F., Danis E.H., Del Vecchio P.J., Rosano C.L. Enhancement of intracellular glutathione protects endothelial cells against oxidant damage. Biochem. Biophys. Res. Co. 1985, 127:270-276.
56. Tsan M.F., White J.E., Rosano C.L. Modulation of endothelial GSH concentrations: effect of exogenous GSH and GSH monoethyl ester. J. Appl. Physiol. 1989, 66:1029-1034.
57. United States 106th Congress - Public Law 106-545, December 19, 2000.
58. Venkatachari P., Hopke P.K., Grover B.D., Eatough D.J. Measurement of particle-bound reactive oxygen species in rubidoux aerosols. J. Atmos. Chem. 2005, 50:49-58.
59. Vlahopoulos S., Boldogh I., Casola A., Brasier A.R. Nuclear factor-kB-dependent induction of interleukin-8 gene expression by tumor necrosis factor-α: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation. Blood 1999, 94:1878-1889.
60. Watson P., Jones A.T., Stephens D.J. Intracellular trafficking pathways and drug delivery: fluorescence imaging of living and fixed cells. Adv. Drug Deliver. Rev. 2005, 57:43-61.
61. Xia T., Kovochich M., Brant J., Hotze M., Sempf J., Oberley T., Sioutas C., Yeh J.I., Wiesner M.R., Nel A.E. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett. 2006, 6:1794-1807.
62. Zhou J., Wu J., Hafdi N., Behr J.P., Erbacher P., Peng L. PAMAM dendrimers for efficient siRNA delivery and potent gene silencing. Chem. Commun. 2006, 22:2362-2364.
63. Zi Z., Zheng Y., Rundell A.E., Klipp E. SBML-SAT: a systems biology markup language (SBML) based sensitivity analysis tool. BMC Bioinformatics 2008, 9:342.